Praxis Precision Medicines Inc (PRAX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PRAX Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Praxis Precision Medicines Inc.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent1,400.00
Marketable Securities, Current SH283.79
Cash & Short-term Investments1,683.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current13.35
Total Current Assets771.90
Equipment/Property/Plant Net0.49
Intangible Assets0.77
Long-term investments615.29
Other Assets, Noncurrent1.64
Operating Lease Right Of Use Asset1.32
Total Assets1,390.10
Liabilities
Accounts Payable, Current AC23.39
Accrued Liabilities, Current AC24.59
Other Liabilities, Current1.09
Total Current Liabilities49.06
Total Long-term Debt0.00
Operating Lease Liability Current1.44
Total Liabilities49.06
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock2,659.99
Retained Earnings / Accumulated Deficit-1,316.29
Accumulated Other Comprehensive Income-2.67
Other Equity-2.67
Common Stockholder's Equity1,341.04
Total Stockholder's Equity1,341.04
Liabilities & Stockholder's Equity1,390.10
4 historic quarters locked

Sign in to unlock the full Praxis Precision Medicines Inc balance sheet history.

About Praxis Precision Medicines Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001689548-26-000083

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.